Skip to main content
NC Medicaid logo NC Medicaid

Topical Navigation

  • Home
  • Beneficiaries
  • Meetings & Notices
  • Find a Doctor
  • Providers
  • Counties
  • Reports
  • ABOUT US
  • NC.GOV
  • NCDHHS
  • SERVICES
NC Medicaid »   Home »   blog

SPECIAL BULLETIN COVID-19 #137: Reimbursement for COVID-19 Related Primary Care Services for Uninsured NC Residents – Steps to Prepare

October 2, 2020

North Carolina Department of Health and Human Services (DHHS) developed a program to reimburse primary care providers (PCP) with federal funds for providing medical care for COVID-19 related services (e.g. follow-up care) to uninsured North Carolina residents. While the portal to submit claims will not be live until late October, claims will be reimbursed retroactively to Sept. 1, 2020. It is important to understand the program qualifications and steps you can take now to prepare. 

Key Program Facts: 

  • $7.8M is available to support the program through Dec. 30, 2020, or until the funds are depleted, whichever occurs first. 
  • A payment of $150 per eligible encounter enables providers to recoup costs for COVID-19 related services provided for uninsured patients. 
  • This new program follows the launch of the Optional COVID-19 Testing Program, which provides reimbursement for testing costs for uninsured and qualified NC residents.

Eligibility

Individuals are eligible for the program if they are North Carolina residents and have no health care coverage (e.g. Medicaid, Medicare, or other health insurance). Eligible providers are PCPs that operate in the state of North Carolina and are registered in NCTracks, North Carolina’s Medicaid payment platform. 

NCTracks Attestation Form includes the following language: By submitting this transaction to the NC Department of Health and Human Services, I attest that the service performed is accurately represented as shown, and the patient was uninsured, and the service was a COVID-19 related primary care service. I further attest that claims have been either submitted to the HRSA portal and denied or were not submitted because they were ineligible for HRSA reimbursement. I understand this transaction is a request for payment from CARES Act funding and is subject to audit by the Office of the State Auditor and other oversight organizations.

Action Items for Providers:

  1. Confirm enrollment as a provider in NCTracks. If the provider is not enrolled, they should complete enrollment through the NCTracks portal.
  2. Ensure patient does not have medical insurance.
  3. Continue providing COVID-19 related care to patients. Hold all eligible encounter information (no earlier than Sept. 1, 2020) until the portal is live. 
  4. Submit all qualifying claims and continue to submit regular claims as frequently as possible once the portal is open.

Funding is first-come, first-served until exhausted, or on Dec. 30, 2020, whichever comes first. PCPs will be reimbursed in subsequent NCTracks checkwrites issued by the Division of Health Benefits.

More Information

For more information, review the fact sheet. Stay tuned for additional communications regarding the uninsured portal and training opportunities. 

This blog is related to:

  • Bulletins
  • All Providers
  • COVID-19

Related Articles

  • Billing Requirement Modifications Due to COVID-19 to Expire
  • Verifying Provider Information (NPI+Location Code) in NCTracks
  • Lutetium Lu 177 Vipivotide Tetraxetan Injection, for Intravenous Use (Pluvicto™) HCPCS Code A9699: Billing Guidelines
  • Kit for the Preparation of Gallium Ga 68 Dotatate Injection, for Intravenous Use (Netspot®) HCPCS Code A9587: Billing Guidelines
  • Kit for the Preparation of Gallium Ga 68 Gozetotide Injection, for Intravenous Use (Locametz®) HCPCS Code A9597: Billing Guidelines
  • Gadoterate Meglumine Injection, for Intravenous Use (Clariscan™) HCPCS Code A9575: Billing Guidelines
  • Free Dental Continuing Education Credits
  • Ephedrine Hydrochloride Injection, for Intravenous use (Rezipres®) HCPCS code J3490: Billing Guidelines
  • Filgrastim-ayow Injection, for Subcutaneous or Intravenous Use (Releuko®) HCPCS Code J3590: Billing Guidelines
  • Nivolumab and Relatlimab-rmbw Injection, for Intravenous Use (Opdualag™) HCPCS Code J9999: Billing Guidelines
  • Difelikefalin Injection, for Intravenous use (Korsuva™) HCPCS code J0879 - Injection, difelikefalin, 0.1 microgram, (for ESRD on Dialysis): Billing Guidelines
  • Sutimlimab-jome Injection, for Intravenous Use (Enjaymo™) HCPCS Code J3590: Billing Guidelines
  • One Year Anniversary of New Service to Ensure Communication Access in Health Care Settings
  • SPECIAL BULLETIN COVID-19 #247: Over-the-Counter COVID-19 Tests for Home Use Pharmacy Coverage
  • Healthy Opportunities Housing and Transportation Services Available

Share this page:

  • Facebook
  • Twitter
  • Email
Back to top

Contact Information

NC Medicaid
Division of Health Benefits

2501 Mail Service Center
Raleigh, NC 27699-2501
 
NC Medicaid Contact Center
Phone: 888-245-0179
Monday-Friday 8 a.m. to 5 p.m.
Closed on State holidays. 
 
Visit RelayNC for information about TTY services. 
 
More
 

Recent Tweets

Tweets by @ncdhhs

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • EMPLOYEE DIRECTORY
  • TRANSLATION DISCLAIMER
  • Accessibility
  • Terms of Use
  • Privacy Policy
  • Open Budget
NC Medicaid
https://medicaid.ncdhhs.gov/blog/2020/10/02/special-bulletin-covid-19-137-reimbursement-covid-19-related-primary-care-services